LECTUS THERAPEUTICS
Lectus Therapeutics Limited is a UK-based pharmaceutical company. Its mission is to build a development pipeline containing first-in-class ion channel therapeutics identified through the use of its proprietary proteomics technology for pain management and the treatment of urinary bladder disorders.
LECTUS THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.lectustherapeutics.com
Status:
Closed
Contact:
44 1223 499050
Email Addresses:
[email protected]
Total Funding:
20.33 M USD
Technology used in webpage:
DNS.COM Peg Technic
Investors List
Wellcome Trust
Wellcome Trust investment in Venture Round - Lectus Therapeutics
Takeda Ventures
Takeda Ventures investment in Series A - Lectus Therapeutics
Quester Capital
Quester Capital investment in Series A - Lectus Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - Lectus Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Lectus Therapeutics
Sulis Innovation
Sulis Innovation investment in Seed Round - Lectus Therapeutics
Official Site Inspections
http://www.lectustherapeutics.com
- Host name: 192.64.119.239
- IP address: 192.64.119.239
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Lectus Therapeutics"
Lectus Therapeutics - Crunchbase Company Profile & Funding
Lectus Therapeutics Limited is a UK-based pharmaceutical company. Its mission is to build a development pipeline containing first-in-class ion channel therapeutics identified through the …See details»
Lectus Therapeutics Company Profile 2024: Valuation, Investors ...
Operator of a drug discovery and development company intended to focus on next-generation ion channel modulators. The company offers ion-channel modulators for a range of illnesses …See details»
Lectus Therapeutics - VentureRadar
Website: http://www.lectustherapeutics.com/ Lectus Therapeutics Limited (LTL) is a pharmaceutical company based in the United Kingdom. LTL specialized in the discovery and …See details»
Lectus Therapeutics (Pharmaceutical Business and Assets)
Information on acquisition, funding, cap tables, investors, and executives for Lectus Therapeutics (Pharmaceutical Business and Assets). Use the PitchBook Platform to explore the full profile.See details»
Lectus Therapeutics Ltd - Company Profile and News
Lectus Therapeutics Limited operates as a pharmaceutical company. The Company offers discovery and development of novel drug candidates within the therapeutic areas of …See details»
Lectus Therapeutics Ltd. - VentureRadar
Find out more about Lectus Therapeutics Ltd. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Lectus Therapeutics - Ownership and Business Overview - Mergr
Lectus Therapeutics is an emerging UK-based drug-discovery and development company, incorporated in December 2002, specialising in the discovery and development of novel drugs …See details»
Lectus Therapeutics - SelectScience
Lectus Therapeutics is an emerging UK-based drug-discovery and development company, incorporated in December 2002, specialising in the discovery and development of novel drugs …See details»
Lectus Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Lectus Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
Lectus Therapeutics - Funding, Financials, Valuation & Investors
Lectus Therapeutics is a drug discovery and development company.See details»
Lectus Therapeutics - Products, Competitors, Financials, Employees ...
Lectus Therapeutics is a UK biopharmaceutical company with a proprietary functional proteomics screening platform (LEPTICS), enabling the discovery and development of novel, small …See details»
Lectus Therapeutics - Pharmaceutical Assets - Ownership and
Nov 22, 2011 · Lectus Therapeutics - Pharmaceutical Assets engages in the discovery and development of Lectus' drug for the treatment of central nervous system. LEPTICS technology …See details»
Lectus Therapeutics Ltd. - life-sciences-europe.com
Upcoming Events. BMSS-BSPR Super Meeting 2024 Warwick (BMSS 2024) Morgan Stanley Global Healthcare Conference 2024 New York; Goldman Sachs European Medtech and …See details»
Lectus Therapeutics - Apollo.io
Lectus Therapeutics Limited is a UK-based pharmaceutical company. Its mission is to build a development pipeline containing first-in-class ion channel therapeutics identified through the …See details»
Changing the channel | Drug Discovery News
Jan 9, 2012 · BRUSSELS, Belgium—UCB, a global biopharmaceutical companywith a focus on severe diseases such as central nervous system (CNS) diseasesand immunology issues, …See details»
Lectus Therapeutics - Tech Stack, Apps, Patents & Trademarks
Lectus Therapeutics uses 7 technology products and services including HTML5, jQuery, and Bootstrap, according to G2 Stack. Lectus Therapeutics is actively using 14 technologies for its …See details»
UCB : acquires Lectus Therapeutics’ key pharmaceutical assets
Nov 22, 2011 · UCB has acquired Lectus Therapeutics's key pharmaceutical assets today via a licence and acquisition agreement. Lectus Therapeutics Ltd is a drug discovery and …See details»
What is Lectus Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Lectus Therapeutics. Salaries, reviews, and more - all posted by employees working at Lectus Therapeutics.See details»
OcuTerra
Administered as a topical eye drop, OTT166 has the potential to transform standard of care. OTT166 Inhibits Integrins Central to Diabetic Retinal Disease. Creating a clear vision for the …See details»